Abstract
C677T (rs1801133) and A1298C (rs1801131) MTHFR gene polymorphisms and/or nutritional deficiency of folate/vitamin B12 leading to hyperhomocysteinemia is an established risk factor for CAD. The objective of this study was to evaluate the clinical usefulness of association between MTHFR C677T (rs1801133) and A1298C (rs1801131) polymorphisms with serum homocysteine, folate and vitamin B12 in addition to conventional cardiovascular risk factors in patients with young CAD. Genomic DNA was isolated from the whole blood. Genotyping of MTHFR C677T (rs1801133) and MTHFR A1298C (rs1801131) polymorphisms in young CAD patients and healthy controls was performed by ARMS-PCR method. Serum homocysteine, vitamin B12 and folate were estimated by CMIA and lipid profile parameters were measured by automated chemistry analyzers. Serum homocysteine levels were significantly higher but serum folate and vitamin B12 levels were not significantly different among young CAD group as compared to control group. Statistically significant hyperhomocysteinemia was observed in carriers of T allele for MTHFR 677C/T (rs1801133) genotype in young CAD group but this association was not significant for MTHFR 1298A/C (rs1801131) polymorphism. The association between hyperhomocysteinemia and CAD in young group was not independent of conventional cardiovascular risk factors. Risk of hyperhomocysteinemia and young CAD could be monitored by MTHFR polymorphism detection followed by serum homocysteine, folate and vitamin B12 measurements. The findings could help to prevent or delay the occurrence of young CAD through appropriate measures.
Similar content being viewed by others
References
Iyengar SS, Gupta R, Ravi S, Thangam S, Thomas A, Manjunath CN, et al. Premature coronary artery disease in India: coronary artery disease in the young (CADY) registry. Indian Heart J. 2017;69(2):211–6.
Ma Y, Peng D, Liu C, Huang C, Luo J. Serum high concentrations of homocysteine and low levels of folic acid and vitamin B12 are significantly correlated with the categories of coronary artery diseases. BMC CardiovascDisord. 2017;17(1):37.
Gupta SK, Kotwal J, Kotwal A, Dhall A, Garg S. Role of homocysteine & MTHFR C677T gene polymorphism as risk factors for coronary artery disease in young Indians. Indian J Med Res. 2012;135(4):506–12.
Butler S, Young A, Akam EC, Sinha N, Agrawal S, Mastana S. Association of methylenetetrahydrofolatereductase (MTHFR) C677T and A1298C polymorphisms with coronary artery disease (CAD) in a North Indian population. Cogent Med. 2018;5(1):1–11.
Friso S, Girelli D, Trabetti E, Stranieri C, Olivieri O, Tinazzi E, et al. A1298C methylenetetrahydrofolatereductase mutation and coronary artery disease: relationships with C677T polymorphism and homocysteine/folate metabolism. Clin Exp Med. 2002;2(1):7–12.
Roeschlau P, Bernt E, Gruber W. Enzymatic determination of total cholesterol in serum. Z Klin Chem Klin Biochem. 1974;12(5):226.
Warnick GR, Nauck M, Rifai N. Evolution of methods for measurement of HDL-cholesterol: from ultracentrifugation to homogeneous assays. Clin Chem. 2001;47(9):1579–96.
Bucolo G, David H. Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem. 1973;19(5):476–82.
Klee GG. Cobalamin and folate evaluation: measurement of methylmalonic acid and homocysteinevs vitamin B(12) and folate. Clin Chem. 2000;46(8 Pt 2):1277–83.
Chacon-Cortes D, Griffiths L. Methods for extracting genomic DNA from whole blood samples: current perspectives. J Biorepos Sci Appl Med. 2014;2:1–9. https://doi.org/10.2147/BSAM.S46573.
Angeline T, Aruna RM, Ramadevi K, Mohan G, Jeyaraj N. Homocysteine status and acute myocardial infarction among Tamilians. Indian J Clin Biochem. 2005;20(1):18–20.
Shenoy V, Mehendale V, Prabhu K, Shetty R, Rao P. Correlation of serum homocysteine levels with the severity of coronary artery disease. Indian J Clin Biochem. 2014;29(3):339–44.
Kluijtmans LA, Van den Heuvel LP, Boers GH, Frosst P, Stevens EM, Van Oost BA, et al. Molecular genetic analysis in mild hyperhomocysteinemia: a common mutation in the methylenetetrahydrofolatereductase gene is a genetic risk factor for cardiovascular disease. Am J Hum Genet. 1996;58(1):35–41.
Falchi A, Giovannoni L, Piras IS, Caló Maria C, Moral Pedro, Vona Giuseppe, et al. Prevalence of genetic risk factors for coronary artery disease in Corsica island (France). ExpMolPathol. 2005;79(3):210–3.
Ma J, Stampfer MJ, Hennekens CH, Frosst P, Selhub J, Horsford J, et al. Methylenetetrahydrofolatereductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians. Circulation. 1996;94(10):2410–6.
Schmitz C, Lindpaintner K, Verhoef P, Gaziano JM, Buring J. Genetic polymorphism of methylenetetrahydrofolatereductase and myocardial infarction. A Case-Control Study Circ. 1996;94(8):1812–4.
Chambers JC, Ireland H, Thompson E, Reilly P, Obeid OA, Refsum H, et al. Methylenetetrahydrofolatereductase 677 C–>T mutation and coronary heart disease risk in UK Indian Asians. Arterioscler Thromb Vasc Biol. 2000;20(11):2448–52.
Ilhan N, Kucuksu M, Kaman D, Ilhan N, Ozbay Y. The 677 C/T MTHFR polymorphism is associated with essential hypertension, coronary artery disease, and higher homocysteine levels. Arch Med Res. 2008;39(1):125–30.
Chambers JC, Obeid OA, Refsum H, Ueland P, Hackett D, Hooper J, et al. Plasma homocysteine concentrations and risk of coronary heart disease in UK Indian Asian and European men. The Lancet. 2000;355(9203):523–7.
Kadziela J, Janas J, Dzielinska Z, Szperl M, Gazdzik D, Chotkowska E, et al. The C677T mutation in methylenetetrahydrofolatereductase gene, plasma homocysteine concentrationand the risk of coronary artery disease. Kardiol Pol. 2003;59(7):17–26.
Mager A, Battler A, Birnbaum Y, Magal N, Shohat M. Plasma homocysteine, methylenetetrahydrofolatereductase genotypes, and age at onset of symptoms of myocardial ischemia. Am J Cardiol. 2002;89(8):919–23.
Mager A, Lalezari S, Shohat T, Birnbaum Y, Adler Y, Magal N, et al. Methylenetetrahydrofolatereductase genotypes and early-onset coronary artery disease. Circulation. 1999;100(24):2406–10.
Zee RYL, Mora S, Cheng S, Erlich HA, Lindpaintner K, Nader R, et al. Homocysteine, 5,10-methylene tetrehydrofolatereductase 677 C>T polymorphism, nutrient intake and incident cardiovascular disease in 24968 initially healthy women. Clin Chem. 2007;53:845–51.
Lin PT, Huang MC, Lee BJ, Chang CH, Tsai TP, Huang YC, et al. High plasma homocysteine is associated with the risk of coronary artery disease independent of methylene tetrahydrofolate reductase 677 C→T genes. Asia Pac J ClinNutr. 2008;17:330–8.
Kolling K, Ndrepepa G, Koch W, Braun S, Mehilli J, Schomig A. Methylenetetrahydrofolatereductase gene C677T and A1298C polymorphisms, plasma homocysteine, folate, and vitamin B12 levels and the extent of coronary artery disease. Am J Cardiol. 2004;93(10):1201–6.
Spiroski I, Kedev S, Antov S, Arsov T, Krstevska M, Dzhekova-Stojkova S, et al. Association of methylenetetrahydrofolatereductase (MTHFR-677 and MTHFR-1298) genetic polymorphisms with occlusive artery disease and deep venous thrombosis in Macedonians. Croat Med J. 2008;49(1):39–49.
Domagala TB, Adamek L, Nizankowska E, Sanak M, Szczeklik A. Mutations C677T and A1298C of the 5,10-methylenetetrahydrofolate reductase gene and fasting plasma homocysteine levels are not associated with the increased risk of venous thromboembolic disease. Blood Coagul Fibrinolysis. 2002;13(5):423–31.
Hanson NQ, Aras O, Yang F, Tsai MY. C677T and A1298C polymorphisms of the methylenetetrahydrofolatereductase gene: incidence and effect of combined genotypes on plasma fasting and post-methionine load homocysteine in vascular disease. Clin Chem. 2001;47(4):661–6.
Acknowledgements
We would like to thank Dr. Anant A. Takalkar, MBBS, MD, Professor in Community Medicine and consultant Statistician, Dept. of Community Medicine, MIMSR Medical College, Latur (Maharashtra) for his valuable help in statistical analysis of this project.
Funding
This work was supported by Bharati Vidyapeeth (Deemed to be) University, Pune (Grant number: BVDU/Research Cell/2016–17/929).
Author information
Authors and Affiliations
Contributions
All authors have accepted responsibility for the entire content of this manuscript and approved its submission.
Corresponding author
Ethics declarations
Conflict of interests
Authors state no conflict of interest.
Informed consent
Informed consent was obtained from all individuals included in this study.
Ethical approval
Research involving human subjects complied with all relevant national regulations, institutional policies and has been approved by the institutional ethical committee of Bharati Vidyapeeth (Deemed to be) University Medical college, Pune [BVDUMC/IEC/9A dated 30/04/2018].
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Shivkar, R.R., Gawade, G.C., Padwal, M.K. et al. Association of MTHFR C677T (rs1801133) and A1298C (rs1801131) Polymorphisms with Serum Homocysteine, Folate and Vitamin B12 in Patients with Young Coronary Artery Disease. Ind J Clin Biochem 37, 224–231 (2022). https://doi.org/10.1007/s12291-021-00982-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12291-021-00982-1